Xalkori

Pronunciation

A drug used to treat advanced non-small cell lung cancer that has a mutated (changed) form of a gene called anaplastic lymphoma kinase (ALK). It is also being studied in the treatment of other types of cancer. Xalkori blocks the protein made by the mutated ALK gene. Blocking this protein may stop the growth and spread of cancer cells. Xalkori may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called crizotinib, MET tyrosine kinase inhibitor PF-02341066, and PF-02341066. (NCI Dictionary)

YOU MAY ALSO LIKE

Xaliproden Hydrochloride

The hydrochloride salt of xaliproden, an orally-active, synthetic, non-peptidic 5-hydroxytryptamine (5-HT) 1A receptor agonist with neurotrophic and neuroprotective activities. Although its mechanism…

XAGE3 wt Allele

Human XAGE3 wild-type allele is located within Xp11.22-p11.21 and is approximately 6 kb in length. This allele, which encodes G antigen family…

XAGE3 Gene

This gene may play a role in placental function.

XAGE2 wt Allele

Human XAGE2 wild-type allele is located in the vicinity of Xp11.22 and is approximately 7 kb in length. This allele, which encodes…

XAGE2 Gene

This gene plays a role in the immune response.

XAGE1 Family Gene

A subfamily of the GAGE gene family that is comprised of at least 5 nearly identical loci clustered in the vicinity of…